Amicus Therapeutics
FOLD
FOLD
289 hedge funds and large institutions have $3.28B invested in Amicus Therapeutics in 2024 Q3 according to their latest regulatory filings, with 57 funds opening new positions, 90 increasing their positions, 93 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
3% less repeat investments, than reductions
Existing positions increased: 90 | Existing positions reduced: 93
2.92% less ownership
Funds ownership: 106.4% → 103.48% (-2.9%)
29% less call options, than puts
Call options by funds: $6.37M | Put options by funds: $8.9M
Holders
289
Holding in Top 10
6
Calls
$6.37M
Puts
$8.9M
Top Buyers
| 1 | +$30.5M | |
| 2 | +$27.6M | |
| 3 | +$18.7M | |
| 4 |
BlackRock
New York
|
+$18.5M |
| 5 |
Goldman Sachs
New York
|
+$18.2M |
Top Sellers
| 1 | -$73.7M | |
| 2 | -$45.1M | |
| 3 | -$27.7M | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$25.1M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$24.1M |